Chang Gung Medical Foundation-Kaohsiung

Kaohsiung City 833401

1 studies enrolling now · 5 studies all time

What they study most

Acute Myeloid Leukemia, Acute Myocardial Infarction, Advanced Gastrointestinal (GI) Malignancies, Colorectal Cancer, Gastric Cancer, Hepatocellular Carcinoma, Mesothelioma, UC (Urothelial Cancer)

Studies at this site

• Selatogrel Outcome Study in Suspected Acute Myocardial Infarction — Enrolling by invitation
• Pembrolizumab in Combination With Epacadostat or Placebo in Cisplatin-ineligible Urothelial Carcinoma (KEYNOTE-672/ECHO-307) — Completed
• Ph 2/3 Study in Subjects With MPM to Assess ADI-PEG 20 With Pemetrexed and Cisplatin — Completed
• Ph 1-2 Study ADI-PEG 20 Plus FOLFOX in Subjects With Advanced GI Malignancies Focusing on Hepatocellular Carcinoma — Stopped early
• PH 2 ADI-PEG 20 Acute Myeloid Leukemia — Completed